annual working capital:
$14.72B-$1.34B(-8.34%)Summary
- As of today (June 29, 2025), REGN annual working capital is $14.72 billion, with the most recent change of -$1.34 billion (-8.34%) on December 31, 2024.
- During the last 3 years, REGN annual working capital has risen by +$4.63 billion (+45.96%).
- REGN annual working capital is now -8.34% below its all-time high of $16.06 billion, reached on December 31, 2023.
Performance
REGN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$14.01B-$711.50M(-4.83%)Summary
- As of today (June 29, 2025), REGN quarterly working capital is $14.01 billion, with the most recent change of -$711.50 million (-4.83%) on March 31, 2025.
- Over the past year, REGN quarterly working capital has dropped by -$1.29 billion (-8.41%).
- REGN quarterly working capital is now -12.77% below its all-time high of $16.06 billion, reached on December 31, 2023.
Performance
REGN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
REGN Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -8.4% |
| 3 y3 years | +46.0% | +24.0% |
| 5 y5 years | +163.2% | +112.6% |
REGN Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +46.0% | -12.8% | +24.0% |
| 5 y | 5-year | -8.3% | +163.2% | -12.8% | +236.8% |
| alltime | all time | -8.3% | >+9999.0% | -12.8% | >+9999.0% |
REGN Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $14.01B(-4.8%) |
| Dec 2024 | $14.72B(-8.3%) | $14.72B(-6.1%) |
| Sep 2024 | - | $15.67B(+0.6%) |
| Jun 2024 | - | $15.57B(+1.8%) |
| Mar 2024 | - | $15.29B(-4.8%) |
| Dec 2023 | $16.06B(+26.0%) | $16.06B(+6.8%) |
| Sep 2023 | - | $15.04B(+8.8%) |
| Jun 2023 | - | $13.82B(+0.1%) |
| Mar 2023 | - | $13.81B(+8.4%) |
| Dec 2022 | $12.74B(+26.4%) | $12.74B(+1.5%) |
| Sep 2022 | - | $12.55B(+0.4%) |
| Jun 2022 | - | $12.50B(+10.6%) |
| Mar 2022 | - | $11.30B(+12.1%) |
| Dec 2021 | $10.08B(+42.4%) | $10.08B(+0.2%) |
| Sep 2021 | - | $10.06B(+4.7%) |
| Jun 2021 | - | $9.61B(+40.5%) |
| Mar 2021 | - | $6.84B(-3.5%) |
| Dec 2020 | $7.08B(+26.6%) | $7.08B(+4.8%) |
| Sep 2020 | - | $6.76B(+62.6%) |
| Jun 2020 | - | $4.16B(-36.9%) |
| Mar 2020 | - | $6.59B(+17.8%) |
| Dec 2019 | $5.59B(+11.7%) | $5.59B(+4.7%) |
| Sep 2019 | - | $5.34B(+8.2%) |
| Jun 2019 | - | $4.94B(-8.8%) |
| Mar 2019 | - | $5.42B(+8.2%) |
| Dec 2018 | $5.00B(+56.4%) | $5.00B(+16.3%) |
| Sep 2018 | - | $4.30B(+23.5%) |
| Jun 2018 | - | $3.48B(+6.2%) |
| Mar 2018 | - | $3.28B(+2.5%) |
| Dec 2017 | $3.20B(+65.0%) | $3.20B(+6.8%) |
| Sep 2017 | - | $3.00B(+5.9%) |
| Jun 2017 | - | $2.83B(+19.9%) |
| Mar 2017 | - | $2.36B(+21.8%) |
| Dec 2016 | $1.94B(-7.9%) | $1.94B(-23.7%) |
| Sep 2016 | - | $2.54B(+12.5%) |
| Jun 2016 | - | $2.26B(+2.0%) |
| Mar 2016 | - | $2.21B(+5.2%) |
| Dec 2015 | $2.10B(+47.1%) | $2.10B(+8.4%) |
| Sep 2015 | - | $1.94B(+15.4%) |
| Jun 2015 | - | $1.68B(-5.2%) |
| Mar 2015 | - | $1.77B(+24.1%) |
| Dec 2014 | $1.43B(-4.5%) | $1.43B(-20.1%) |
| Sep 2014 | - | $1.79B(+14.2%) |
| Jun 2014 | - | $1.57B(+0.1%) |
| Mar 2014 | - | $1.57B(+4.5%) |
| Dec 2013 | $1.50B(+43.7%) | $1.50B(+9.7%) |
| Sep 2013 | - | $1.37B(+0.6%) |
| Jun 2013 | - | $1.36B(+22.3%) |
| Mar 2013 | - | $1.11B(+6.5%) |
| Dec 2012 | $1.04B(+101.4%) | $1.04B(+35.4%) |
| Sep 2012 | - | $770.03M(+31.4%) |
| Jun 2012 | - | $585.97M(+9.2%) |
| Mar 2012 | - | $536.53M(+3.7%) |
| Dec 2011 | $517.51M(+108.2%) | $517.51M(+150.4%) |
| Sep 2011 | - | $206.64M(-25.5%) |
| Jun 2011 | - | $277.40M(+30.1%) |
| Mar 2011 | - | $213.25M(-14.2%) |
| Dec 2010 | $248.57M(-25.1%) | $248.57M(-43.7%) |
| Sep 2010 | - | $441.89M(+48.2%) |
| Jun 2010 | - | $298.18M(+2.3%) |
| Mar 2010 | - | $291.35M(-12.2%) |
| Dec 2009 | $331.93M(-24.2%) | $331.93M(-4.5%) |
| Sep 2009 | - | $347.43M(+0.8%) |
| Jun 2009 | - | $344.61M(-9.5%) |
| Mar 2009 | - | $380.68M(-13.0%) |
| Dec 2008 | $437.77M | $437.77M(-12.1%) |
| Sep 2008 | - | $497.77M(-4.0%) |
| Jun 2008 | - | $518.48M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $501.55M(-2.5%) |
| Dec 2007 | $514.16M(+21.0%) | $514.16M(+58.0%) |
| Sep 2007 | - | $325.33M(-17.0%) |
| Jun 2007 | - | $392.15M(-3.3%) |
| Mar 2007 | - | $405.56M(-4.6%) |
| Dec 2006 | $424.97M(+41.2%) | $424.97M(+76.3%) |
| Sep 2006 | - | $241.05M(-7.1%) |
| Jun 2006 | - | $259.55M(-9.2%) |
| Mar 2006 | - | $285.98M(-5.0%) |
| Dec 2005 | $301.04M(-2.8%) | $301.04M(+3.3%) |
| Sep 2005 | - | $291.44M(-11.5%) |
| Jun 2005 | - | $329.36M(-3.1%) |
| Mar 2005 | - | $339.92M(+9.7%) |
| Dec 2004 | $309.82M(+25.3%) | $309.82M(+12.5%) |
| Sep 2004 | - | $275.34M(-20.4%) |
| Jun 2004 | - | $345.96M(-2.8%) |
| Mar 2004 | - | $355.95M(+43.9%) |
| Dec 2003 | $247.28M(+4.4%) | $247.28M(-29.3%) |
| Sep 2003 | - | $349.64M(+42.1%) |
| Jun 2003 | - | $246.09M(-9.0%) |
| Mar 2003 | - | $270.37M(+14.2%) |
| Dec 2002 | $236.83M(-36.4%) | $236.83M(-15.8%) |
| Sep 2002 | - | $281.17M(-2.4%) |
| Jun 2002 | - | $288.23M(-8.3%) |
| Mar 2002 | - | $314.17M(-15.6%) |
| Dec 2001 | $372.16M(+209.2%) | $372.16M(+56.2%) |
| Sep 2001 | - | $238.31M(-0.6%) |
| Jun 2001 | - | $239.86M(-12.1%) |
| Mar 2001 | - | $272.78M(+126.6%) |
| Dec 2000 | $120.36M(+101.6%) | $120.36M(-3.1%) |
| Sep 2000 | - | $124.26M(-0.1%) |
| Jun 2000 | - | $124.44M(+103.9%) |
| Mar 2000 | - | $61.03M(+2.2%) |
| Dec 1999 | $59.70M(-28.5%) | $59.70M(-8.6%) |
| Sep 1999 | - | $65.30M(-3.3%) |
| Jun 1999 | - | $67.50M(+1.8%) |
| Mar 1999 | - | $66.30M(-20.6%) |
| Dec 1998 | $83.50M(-6.1%) | $83.50M(+4.9%) |
| Sep 1998 | - | $79.60M(-0.4%) |
| Jun 1998 | - | $79.90M(-4.2%) |
| Mar 1998 | - | $83.40M(-6.2%) |
| Dec 1997 | $88.90M(+21.8%) | $88.90M(-5.7%) |
| Sep 1997 | - | $94.30M(-5.5%) |
| Jun 1997 | - | $99.80M(+60.5%) |
| Mar 1997 | - | $62.20M(-14.8%) |
| Dec 1996 | $73.00M(+101.1%) | $73.00M(+13.2%) |
| Sep 1996 | - | $64.50M(-10.5%) |
| Jun 1996 | - | $72.10M(+157.5%) |
| Mar 1996 | - | $28.00M(-22.9%) |
| Dec 1995 | $36.30M(+6.5%) | $36.30M(+120.0%) |
| Sep 1995 | - | $16.50M(-29.2%) |
| Jun 1995 | - | $23.30M(-3.7%) |
| Mar 1995 | - | $24.20M(-29.0%) |
| Dec 1994 | $34.10M(-56.7%) | $34.10M(+11.8%) |
| Sep 1994 | - | $30.50M(-9.2%) |
| Jun 1994 | - | $33.60M(0.0%) |
| Mar 1994 | - | $33.60M(-57.3%) |
| Dec 1993 | $78.70M(-1.7%) | $78.70M(-21.5%) |
| Sep 1993 | - | $100.20M(+66.2%) |
| Jun 1993 | - | $60.30M(-14.6%) |
| Mar 1993 | - | $70.60M(-11.9%) |
| Dec 1992 | $80.10M(-22.5%) | $80.10M(-7.5%) |
| Sep 1992 | - | $86.60M(-7.1%) |
| Jun 1992 | - | $93.20M(-5.3%) |
| Mar 1992 | - | $98.40M(-4.7%) |
| Dec 1991 | $103.30M(+401.5%) | $103.30M(-3.9%) |
| Sep 1991 | - | $107.50M(-1.6%) |
| Jun 1991 | - | $109.30M(+430.6%) |
| Dec 1990 | $20.60M | $20.60M |
FAQ
- What is Regeneron Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual working capital year-on-year change?
- What is Regeneron Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly working capital year-on-year change?
What is Regeneron Pharmaceuticals annual working capital?
The current annual working capital of REGN is $14.72B
What is the all time high annual working capital for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual working capital is $16.06B
What is Regeneron Pharmaceuticals annual working capital year-on-year change?
Over the past year, REGN annual working capital has changed by -$1.34B (-8.34%)
What is Regeneron Pharmaceuticals quarterly working capital?
The current quarterly working capital of REGN is $14.01B
What is the all time high quarterly working capital for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly working capital is $16.06B
What is Regeneron Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, REGN quarterly working capital has changed by -$1.29B (-8.41%)